Efficacy and safety of spesolimab for the management of generalized pustular psoriasis: a drug safety evaluation.
Luca PotestioElisa CamelaSara CacciapuotiFabrizio MartoraLuigi GuerrieroLuigi FornaroAngelo RuggieroMatteo MegnaPublished in: Expert opinion on drug safety (2023)
Spesolimab is efficacious and has a consistent and favorable safety profile in patients presenting with a GPP flare. However, despite excellent results in terms of safety and efficacy have been reported by both clinical trials and very limited real-life experiences, long-term data, especially in flare-up prevention, are scant. Thus, while the available data are encouraging, further research is warranted to understand the efficacy, safety, and long-term outcomes associated with spesolimab treatment in GPP.